Sr Dir, Biostatistics

Alkermes; Waltham (MA); Hybrid; USD 275,000 - 294,000; Full time

Benefits offered by this job

Hybrid work model

Job summary

Alkermes seeks a Senior Director, Biostatistics to lead a team of statisticians supporting drug development (Ph I–IV), guiding study design, methods, analyses and reporting.

The role offers a hybrid work model (60% office/40% home) with onsite presence at our Waltham, MA office at least 3 days per week; not eligible for fully remote. Travel up to 15% is expected.

Qualifications

• Ph.D. in Statistics or Biostatistics.
• 16+ years in clinical research and drug development.
• Experience in neuroscience or CNS therapeutics preferred.

Responsibilities

• Work with statisticians supporting drug development activities and decision-making.
• Design and analyze clinical studies using innovative statistical methods.
• Provide oversight of statistical content in regulatory interactions.
• Coordinate statistical efforts with CROs and external organizations.
• Support regulatory submissions with briefing books and integrated summaries.
• Lead strategic input into clinical development plans.
• Interact with senior cross-functional teams.

Skills

Analytical skills

Communication skills

Interpersonal skills

Leadership

Education

Ph.D. in Statistics or Biostatistics

Job description

In this position, the Senior Director, Biostatistics will work with a team of statisticians supporting drug development activities and decision-making encompassing Phase I-IV studies. This includes guidance on designing studies, selecting appropriate and innovative statistical methods, analyses, interpretation, and reporting of study results. Proven experience in strategic input into clinical development plans, and familiarity with regulatory standards and requirements.

Alkermes has recently adopted a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home. This position is eligible for the hybrid workplace model, requiring work to be completed onsite at our Waltham, MA office at least 3 days per week. This role is not eligible for fully remote work.

Why join Team Alkermes?

Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.

We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.

Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.

Basic Requirements:

• Ph.D. in Statistics or Biostatistics
• 16+ years of clinical research and drug development experience

Preferred Requirements:

• Recent or in-depth experience working in the field of neuroscience
• In-depth knowledge of methodologies applied in clinical trials with focus on registration and life cycle management
• Extensive experience of interactions with regulatory agencies- US and Non-US
• Strong analytical skills and demonstrated experience in gathering, interpreting and analyzing data in clinical research and drug development
• Strong communication and interpersonal skills; ability to interact with cross-functional teams
• Flexible to changing priorities, detail-oriented, works well under pressure
• Ability to communicate statistical information to non-scientists, willingness to educate internal team

Travel Expectations:

• Travel domestic and international- up to 15%

The annual base salary for this position ranges from $274,820 to $293,881. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here

• Work with a team of high performing Clinical Biostatisticians with a clear vision in mind to meet corporate regulatory, scientific, and business objectives
• Effectively interact with senior members in other functional areas for strategic planning to ensure optimized clinical development in accordance with corporate objectives
• Design and analyze clinical studies using appropriate and innovative statistical methods
• Provide oversight of statistical and strategic content in support of regulatory interactions
• Effectively coordinate statistical endeavors with outside organizations, CROs and consultants
• Identify and implement emerging new ways of doing clinical development and new methodologies
• Participate in establishment and development of department SOPs
• Oversee vendors with respect to key performance indicators, metrics, and program level deliverables and timelines
• Maintain an active role in planning and preparation of regulatory submissions- briefing books and integrated summary documents